Connect with us

COVID-19

FL Surgeon General: Biden Admin ‘Preventing’ COVID Antibody Treatments

Published

on

Dr. Joseph Ladapo
Dr. Joseph Ladapo

Florida’s surgeon general Dr. Joseph Ladapo has alleged that the Biden administration is “actively preventing” the distribution of monoclonal antibody treatments for COVID-19, causing an “immediate and life-threatening shortage of treatment options.”

Ladapo made the allegations in a letter to Health and Human Services (HHS) Secretary Xavier Becerra on Tuesday, pointing out that the federal government had reduced the number of antibody treatments Florida could receive earlier this year “without any advanced notice.”

“The sudden suspension of multiple monoclonal antibody therapy treatments from distribution to Florida removes a health care provider’s ability to decide the best treatment options for their patients in this state,” Ladapo wrote. “This shortsightedness is especially evident given that the federal government effectively prohibited states from purchasing these monoclonal antibodies and serving their populations directly.”

Ladapo addressed the HHS’s recent decision to pause the distribution of antibody treatments because they were unlikely to be as effective against the Omicron variant, saying federal agencies should not limit Florida’s access to “any available treatments for COVID-19.”

In September, the Biden administration placed restrictions on how COVID-19 monoclonal antibody treatments would be distributed to states, a move that disproportionately harmed Republican-led states.

“Federal health officials plan to allocate specific amounts to each state under the new approach, in an effort to more evenly distribute the 150,000 doses that the government makes available each week,” Politico reported. “The approach is likely to cut into shipments to GOP-led states in the Southeast that have made the pricey antibody-drug a central part of their pandemic strategy, while simultaneously spurning mask mandates and other restrictions.”

Politico pointed out that the decision was a shift from distribution based on an “as-needed basis.”

“Still, until recently, the administration had shipped the antibody treatments to states on an as-needed basis — with top health officials in early August going as far as encouraging those battling the Delta surge to seek even more supply,” the outlet added. “But demand from a handful of southern states has exploded since then, state and federal officials said, raising concerns they were consuming a disproportionate amount of the national supply. Seven states — Texas, Florida, Mississippi, Tennessee, Georgia, Louisiana and Alabama — accounted for 70 percent of all orders in early September.”

Florida Senator Marco Rubio (R) responded to the decision in two different tweets.

“Antibody treatments aren’t a substitute for vaccines,” Rubio tweeted. “But they have prevented thousands of hospitalizations including in breakthrough cases. Now in a move that reeks of partisan payback against states like Florida, the Biden administration is rationing these treatments.”

 

His second tweet contained a video with the caption, “Every day it’s something new with these people in the White House. The decision to ration antibody treatments proves they focused on public health. What they want is power and control.”

 

You may like

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

COVID-19

CIA whistleblower: analysts given money to bury covid lab-leak theory

Published

on

wuhan china lab coronavirus

The House Select Subcommittee on the Coronavirus Pandemic sent a letter to CIA director William Burns discussing the CIA and a COVID-19 cover-up. The letter asserts that it has knowledge from a whistleblower from the CIA’s  “Covid Discovery Team” that was tasked with investigating the origins of the novel coronavirus. “New testimony from a highly credibly whistleblower” alleges that the CIA “rewarded six analysts with significant financial incentives to change their COVID-19 origins conclusion from a lab-leak to zoonosis

Apart from a “lone officer” in the group who believed the virus “originated through zoonosis,” the remaining officials agreed that, on balance of probabilities, the coronavirus was likely the result of a lab-leak.

“According to the whistleblower, at the end of its review, six of the seven members of the Team believed the intelligence and science were sufficient to make a low confidence assessment that Covid-19 originated from a laboratory in Wuhan, China,” the letter reads. “To come to the eventual public determination of uncertainty, the other six members were given a significant monetary incentive to change their position.”

In June, the agency declassified its report that the available evidence on the origins of the coronavirus suggested it “was not genetically engineered.”

 

 

You may like

Continue Reading

Trending